Ads
related to: actemra genentech patient assistance- ACTEMRA® & You Program
Register for ACTEMRA®
Treatment Resources
- Safety Information
Find Side Effect Info For ACTEMRA®
Including Boxed Warning.
- Study Safety Information
View Study Results
And Safety Information
- Important Safety Info
See Important Safety Info
For ACTEMRA®
- ACTEMRA® & You Program
Search results
Results From The WOW.Com Content Network
Tocilizumab, sold under the brand name Actemra among others, is an immunosuppressive drug, used for the treatment of rheumatoid arthritis, systemic juvenile idiopathic arthritis, polyarticular juvenile idiopathic arthritis, giant cell arteritis, cytokine release syndrome, COVID‑19, and systemic sclerosis-associated interstitial lung disease (SSc-ILD).
It is not known if ACTEMRA will harm an unborn baby. Genentech has a registry for pregnant women who take ACTEMRA. Patients who are pregnant or become pregnant while taking ACTEMRA must contact ...
FDA Approves ACTEMRA ® for Children Living with a Rare Form of Arthritis Medicine Offers a New Option for the Treatment of Polyarticular Juvenile Idiopathic Arthritis (PJIA) SOUTH SAN FRANCISCO ...
FDA Approves Expanded Indication for ACTEMRA ® in Rheumatoid Arthritis SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Genentech, Inc., a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY ...
Main page; Contents; Current events; Random article; About Wikipedia; Contact us
Genentech, Inc. is an American biotechnology corporation headquartered in South San Francisco, California, wholly owned by the Swiss multinational pharmaceutical company, the Roche Group. It became an independent subsidiary of Roche in 2009. Genentech Research and Early Development operates as an independent center within Roche. [6]
Ads
related to: actemra genentech patient assistance